Skip to main content
SpringerLink
Log in

Genetic Modeling of Human Blood Cancers in Mice

  • Chapter
  • First Online:
Mouse Models of Human Blood Cancers

  • 591 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Arron, J.R., Pewzner-Jung, Y., Walsh, M.C., Kobayashi, T., and Choi, Y. (2002). Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signaling. J Exp Med 196, 923–934.

    PubMed  CAS  Google Scholar 

  • Bernardin, F., Yang, Y., Cleaves, R., Zahurak, M., Cheng, L., Civin, C.I., and Friedman, A.D. (2002). TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice. Cancer Res 62, 3904–3908.

    PubMed  CAS  Google Scholar 

  • Bernardin-Fried, F., Kummalue, T., Leijen, S., Collector, M.I., Ravid, K., and Friedman, A.D. (2004). AML1/RUNX1 increases during G1 to S cell cycle progression independent of cytokine-dependent phosphorylation and induces cyclin D3 gene expression. J Biol Chem 279, 15678–15687.

    PubMed  CAS  Google Scholar 

  • Bhatia, A., Dash, S., Varma, N., and Marwaha, R.K. (2007). Fanconi anemia presenting as acute myeloid leukemia: a case report. Indian J Pathol Microbiol 50, 441–443.

    Google Scholar 

  • Bichi, R., Shinton, S.A., Martin, E.S., Koval, A., Calin, G.A., Cesari, R., Russo, G., Hardy, R.R., and Croce, C.M. (2002). Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci USA 99, 6955–6960.

    PubMed  CAS  Google Scholar 

  • Borkhardt, A., Haas, O.A., Strobl, W., Repp, R., Mann, G., Gadner, H., and Lampert, F. (1995a). A novel type of MLL/AF10 fusion transcript in a child with acute megakaryocytic leukemia (AML-M7). Leukemia 9, 1796–1797.

    CAS  Google Scholar 

  • Borkhardt, A., Mitteis, M., Brettreich, S., Schlieben, S., Hammermann, J., Repp, R., Kreuder, J., Buchen, U., and Lampert, F. (1995b). Rapid synthesis of hybrid RNA molecules associated with leukemia-specific chromosomal translocations. Leukemia 9, 719–722.

    CAS  Google Scholar 

  • Borrow, J., Stanton, V.P., Jr., Andresen, J.M., Becher, R., Behm, F.G., Chaganti, R.S., Civin, C.I., Disteche, C., Dube, I., Frischauf, A.M., et al. (1996). The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet 14, 33–41.

    PubMed  CAS  Google Scholar 

  • Bowen, D.T., Frew, M.E., Hills, R., Gale, R.E., Wheatley, K., Groves, M.J., Langabeer, S.E., Kottaridis, P.D., Moorman, A.V., Burnett, A.K., et al. (2005). RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years. Blood 106, 2113–2119.

    PubMed  CAS  Google Scholar 

  • Braun, B.S., Tuveson, D.A., Kong, N., Le, D.T., Kogan, S.C., Rozmus, J., Le Beau, M.M., Jacks, T.E., and Shannon, K.M. (2004). Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder. Proc Natl Acad Sci USA 101, 597–602.

    PubMed  CAS  Google Scholar 

  • Buijs, A., Sherr, S., van Baal, S., van Bezouw, S., van der Plas, D., Geurts van Kessel, A., Riegman, P., Lekanne Deprez, R., Zwarthoff, E., Hagemeijer, A., et al. (1995). Translocation (12;22)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. Oncogene 10, 1511–1519.

    PubMed  CAS  Google Scholar 

  • Burel, S.A., Harakawa, N., Zhou, L., Pabst, T., Tenen, D.G., and Zhang, D.E. (2001). Dichotomy of AML1-ETO functions: growth arrest versus block of differentiation. Mol Cell Biol 21, 5577–5590.

    PubMed  CAS  Google Scholar 

  • Callens, C., Chevret, S., Cayuela, J.M., Cassinat, B., Raffoux, E., de Botton, S., Thomas, X., Guerci, A., Fegueux, N., Pigneux, A., et al. (2005). Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group. Leukemia 19, 1153–1160.

    PubMed  CAS  Google Scholar 

  • Carapeti, M., Aguiar, R.C., Goldman, J.M., and Cross, N.C. (1998). A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia. Blood 91, 3127–3133.

    PubMed  CAS  Google Scholar 

  • Castellanos, A., Pintado, B., Weruaga, E., Arevalo, R., Lopez, A., Orfao, A., and Sanchez-Garcia, I. (1997). A BCR-ABL(p190) fusion gene made by homologous recombination causes B-cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous bcr product. Blood 90, 2168–2174.

    PubMed  CAS  Google Scholar 

  • Chaffanet, M., Gressin, L., Preudhomme, C., Soenen-Cornu, V., Birnbaum, D., and Pebusque, M.J. (2000). MOZ is fused to p300 in an acute monocytic leukemia with t(8;22). Genes Chromosomes Cancer 28, 138–144.

    PubMed  CAS  Google Scholar 

  • Chan, I.T., Kutok, J.L., Williams, I.R., Cohen, S., Kelly, L., Shigematsu, H., Johnson, L., Akashi, K., Tuveson, D.A., Jacks, T., et al. (2004). Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease. J Clin Invest 113, 528–538.

    PubMed  CAS  Google Scholar 

  • Chan, I.T., Kutok, J.L., Williams, I.R., Cohen, S., Moore, S., Shigematsu, H., Ley, T.J., Akashi, K., Le Beau, M.M., and Gilliland, D.G. (2006). Oncogenic K-ras cooperates with PML-RAR alpha to induce an acute promyelocytic leukemia-like disease. Blood 108, 1708–1715.

    PubMed  CAS  Google Scholar 

  • Chen, W., Li, Q., Hudson, W.A., Kumar, A., Kirchhof, N., and Kersey, J.H. (2006). A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy. Blood 108, 669–677.

    PubMed  CAS  Google Scholar 

  • Chiarle, R., Gong, J.Z., Guasparri, I., Pesci, A., Cai, J., Liu, J., Simmons, W.J., Dhall, G., Howes, J., Piva, R., et al. (2003). NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. Blood 101, 1919–1927.

    PubMed  CAS  Google Scholar 

  • Collins, S.J., Robertson, K.A., and Mueller, L. (1990). Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha). Mol Cell Biol 10, 2154–2163.

    PubMed  CAS  Google Scholar 

  • Corral, J., Forster, A., Thompson, S., Lampert, F., Kaneko, Y., Slater, R., Kroes, W.G., van der Schoot, C.E., Ludwig, W.D., Karpas, A., et al. (1993). Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation. Proc Natl Acad Sci USA 90, 8538–8542.

    PubMed  CAS  Google Scholar 

  • Dahia, P.L., Aguiar, R.C., Alberta, J., Kum, J.B., Caron, S., Sill, H., Marsh, D.J., Ritz, J., Freedman, A., Stiles, C., et al. (1999). PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanisms in haematological malignancies. Hum Mol Genet 8, 185–193.

    PubMed  CAS  Google Scholar 

  • Daley, G.Q., Van Etten, R.A., and Baltimore, D. (1990). Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 247, 824–830.

    PubMed  CAS  Google Scholar 

  • Dawson, M.I., Elstner, E., Kizaki, M., Chen, D.L., Pakkala, S., Kerner, B., and Koeffler, H.P. (1994). Myeloid differentiation mediated through retinoic acid receptor/retinoic X receptor (RXR) not RXR/RXR pathway. Blood 84, 446–452.

    PubMed  CAS  Google Scholar 

  • de Guzman, C.G., Warren, A.J., Zhang, Z., Gartland, L., Erickson, P., Drabkin, H., Hiebert, S.W., and Klug, C.A. (2002). Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation. Mol Cell Biol 22, 5506–5517.

    PubMed  Google Scholar 

  • Deguchi, K., Ayton, P.M., Carapeti, M., Kutok, J.L., Snyder, C.S., Williams, I.R., Cross, N.C., Glass, C.K., Cleary, M.L., and Gilliland, D.G. (2003). MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP. Cancer Cell 3, 259–271.

    PubMed  CAS  Google Scholar 

  • Demarest, S.J., Martinez-Yamout, M., Chung, J., Chen, H., Xu, W., Dyson, H.J., Evans, R.M., and Wright, P.E. (2002). Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. Nature 415, 549–553.

    PubMed  CAS  Google Scholar 

  • DiMartino, J.F., Miller, T., Ayton, P.M., Landewe, T., Hess, J.L., Cleary, M.L., and Shilatifard, A. (2000). A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL. Blood 96, 3887–3893.

    PubMed  CAS  Google Scholar 

  • Ding, X.F., Anderson, C.M., Ma, H., Hong, H., Uht, R.M., Kushner, P.J., and Stallcup, M.R. (1998). Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Mol Endocrinol 12, 302–313.

    PubMed  CAS  Google Scholar 

  • Dobson, C.L., Warren, A.J., Pannell, R., Forster, A., Lavenir, I., Corral, J., Smith, A.J., and Rabbitts, T.H. (1999). The mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis. Embo J 18, 3564–3574.

    PubMed  CAS  Google Scholar 

  • Domer, P.H., Fakharzadeh, S.S., Chen, C.S., Jockel, J., Johansen, L., Silverman, G.A., Kersey, J.H., and Korsmeyer, S.J. (1993). Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product. Proc Natl Acad Sci USA 90, 7884–7888.

    PubMed  CAS  Google Scholar 

  • Fenrick, R., Amann, J.M., Lutterbach, B., Wang, L., Westendorf, J.J., Downing, J.R., and Hiebert, S.W. (1999). Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein. Mol Cell Biol 19, 6566–6574.

    PubMed  CAS  Google Scholar 

  • Fenske, T.S., Pengue, G., Mathews, V., Hanson, P.T., Hamm, S.E., Riaz, N., and Graubert, T.A. (2004). Stem cell expression of the AML1/ETO fusion protein induces a myeloproliferative disorder in mice. Proc Natl Acad Sci USA 101, 15184–15189.

    PubMed  CAS  Google Scholar 

  • Fischer, M., Schwieger, M., Horn, S., Niebuhr, B., Ford, A., Roscher, S., Bergholz, U., Greaves, M., Lohler, J., and Stocking, C. (2005). Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model. Oncogene 24, 7579–7591.

    PubMed  CAS  Google Scholar 

  • Ford, A.M., Bennett, C.A., Price, C.M., Bruin, M.C., Van Wering, E.R., and Greaves, M. (1998). Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia. Proc Natl Acad Sci USA 95, 4584–4588.

    PubMed  CAS  Google Scholar 

  • Glass, C.K., Rose, D.W., and Rosenfeld, M.G. (1997). Nuclear receptor coactivators. Curr Opin Cell Biol 9, 222–232.

    PubMed  CAS  Google Scholar 

  • Golub, T.R., Barker, G.F., Bohlander, S.K., Hiebert, S.W., Ward, D.C., Bray-Ward, P., Morgan, E., Raimondi, S.C., Rowley, J.D., and Gilliland, D.G. (1995). Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 92, 4917–4921.

    PubMed  CAS  Google Scholar 

  • Golub, T.R., Barker, G.F., Lovett, M., and Gilliland, D.G. (1994). Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77, 307–316.

    PubMed  CAS  Google Scholar 

  • Grisolano, J.L., Wesselschmidt, R.L., Pelicci, P.G., and Ley, T.J. (1997). Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences. Blood 89, 376–387.

    PubMed  CAS  Google Scholar 

  • Heery, D.M., Kalkhoven, E., Hoare, S., and Parker, M.G. (1997). A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387, 733–736.

    PubMed  CAS  Google Scholar 

  • Hess, J.L., and Hug, B.A. (2004). Fusion-protein truncation provides new insights into leukemogenesis. Proc Natl Acad Sci USA 101, 16985–16986.

    PubMed  CAS  Google Scholar 

  • Hess, M., Huggins, M.B., Mudzamiri, R., and Heincz, U. (2004). Avian metapneumovirus excretion in vaccinated and non-vaccinated specified pathogen free laying chickens. Avian Pathol 33, 35–40.

    PubMed  CAS  Google Scholar 

  • Higuchi, M., O'Brien, D., Kumaravelu, P., Lenny, N., Yeoh, E.J., and Downing, J.R. (2002). Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. Cancer Cell 1, 63–74.

    PubMed  CAS  Google Scholar 

  • Honda, H., Inaba, T., Suzuki, T., Oda, H., Ebihara, Y., Tsuiji, K., Nakahata, T., Ishikawa, T., Yazaki, Y., and Hirai, H. (1999). Expression of E2A-HLF chimeric protein induced T-cell apoptosis, B-cell maturation arrest, and development of acute lymphoblastic leukemia. Blood 93, 2780–2790.

    PubMed  CAS  Google Scholar 

  • Horwitz, K.B., Jackson, T.A., Bain, D.L., Richer, J.K., Takimoto, G.S., and Tung, L. (1996). Nuclear receptor coactivators and corepressors. Mol Endocrinol 10, 1167–1177.

    PubMed  CAS  Google Scholar 

  • Hunger, S.P., Ohyashiki, K., Toyama, K., and Cleary, M.L. (1992). Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia. Genes Dev 6, 1608–1620.

    PubMed  CAS  Google Scholar 

  • Ichikawa, H., Shimizu, K., Hayashi, Y., and Ohki, M. (1994). An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. Cancer Res 54, 2865–2868.

    PubMed  CAS  Google Scholar 

  • Ida, K., Kitabayashi, I., Taki, T., Taniwaki, M., Noro, K., Yamamoto, M., Ohki, M., and Hayashi, Y. (1997). Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13). Blood 90, 4699–4704.

    PubMed  CAS  Google Scholar 

  • Imamura, T., Kakazu, N., Hibi, S., Morimoto, A., Fukushima, Y., Ijuin, I., Hada, S., Kitabayashi, I., Abe, T., and Imashuku, S. (2003). Rearrangement of the MOZ gene in pediatric therapy-related myelodysplastic syndrome with a novel chromosomal translocation t(2;8)(p23;p11). Genes Chromosomes Cancer 36, 413–419.

    PubMed  CAS  Google Scholar 

  • Jackson, E.L., Willis, N., Mercer, K., Bronson, R.T., Crowley, D., Montoya, R., Jacks, T., and Tuveson, D.A. (2001). Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15, 3243–3248.

    PubMed  CAS  Google Scholar 

  • Jager, R., Hahne, J., Jacob, A., Egert, A., Schenkel, J., Wernert, N., Schorle, H., and Wellmann, A. (2005). Mice transgenic for NPM-ALK develop non-Hodgkin lymphomas. Anticancer Res 25, 3191–3196.

    PubMed  Google Scholar 

  • Joh, T., Yamamoto, K., Kagami, Y., Kakuda, H., Sato, T., Yamamoto, T., Takahashi, T., Ueda, R., Kaibuchi, K., and Seto, M. (1997). Chimeric MLL products with a Ras binding cytoplasmic protein AF6 involved in t(6;11)(q27;q23) leukemia localize in the nucleus. Oncogene 15, 1681–1687.

    PubMed  CAS  Google Scholar 

  • Kamps, M.P., Look, A.T., and Baltimore, D. (1991). The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials. Genes Dev 5, 358–368.

    PubMed  CAS  Google Scholar 

  • Katsumata, M., Siegel, R.M., Louie, D.C., Miyashita, T., Tsujimoto, Y., Nowell, P.C., Greene, M.I., and Reed, J.C. (1992). Differential effects of Bcl-2 on T and B cells in transgenic mice. Proc Natl Acad Sci USA 89, 11376–11380.

    PubMed  CAS  Google Scholar 

  • Kelly, L.M., Kutok, J.L., Williams, I.R., Boulton, C.L., Amaral, S.M., Curley, D.P., Ley, T.J., and Gilliland, D.G. (2000a). PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model. Proc Natl Acad Sci USA 99, 8283–8288.

    Google Scholar 

  • Kelly, L.M., Liu, Q., Kutok, J.L., Williams, I.R., Boulton, C.L., and Gilliland, D.G. (2002b). FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model. Blood 99, 310–318.

    CAS  Google Scholar 

  • Kitabayashi, I., Aikawa, Y., Nguyen, L.A., Yokoyama, A., and Ohki, M. (2001a). Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein. Embo J 20, 7184–7196.

    CAS  Google Scholar 

  • Kitabayashi, I., Aikawa, Y., Yokoyama, A., Hosoda, F., Nagai, M., Kakazu, N., Abe, T., and Ohki, M. (2001b). Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation. Leukemia 15, 89–94.

    CAS  Google Scholar 

  • Kitabayashi, I., Yokoyama, A., Shimizu, K., and Ohki, M. (1998). Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. Embo J 17, 2994–3004.

    PubMed  CAS  Google Scholar 

  • Kong, X.T., Ida, K., Ichikawa, H., Shimizu, K., Ohki, M., Maseki, N., Kaneko, Y., Sako, M., Kobayashi, Y., Tojou, A., et al. (1997). Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript. Blood 90, 1192–1199.

    PubMed  CAS  Google Scholar 

  • Koschmieder, S., Gottgens, B., Zhang, P., Iwasaki-Arai, J., Akashi, K., Kutok, J.L., Dayaram, T., Geary, K., Green, A.R., Tenen, D.G., et al. (2005). Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis. Blood 105, 324–334.

    PubMed  CAS  Google Scholar 

  • Kottaridis, P.D., Gale, R.E., Frew, M.E., Harrison, G., Langabeer, S.E., Belton, A.A., Walker, H., Wheatley, K., Bowen, D.T., Burnett, A.K., et al. (2001). The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood 98, 1752–1759.

    PubMed  CAS  Google Scholar 

  • Kroon, E., Thorsteinsdottir, U., Mayotte, N., Nakamura, T., and Sauvageau, G. (2001). NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice. Embo J 20, 350–361.

    PubMed  CAS  Google Scholar 

  • Kuefer, M.U., Look, A.T., Pulford, K., Behm, F.G., Pattengale, P.K., Mason, D.Y., and Morris, S.W. (1997). Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice. Blood 90, 2901–2910.

    PubMed  CAS  Google Scholar 

  • Kuhn, R., Schwenk, F., Aguet, M., and Rajewsky, K. (1995). Inducible gene targeting in mice. Science 269, 1427–1429.

    PubMed  CAS  Google Scholar 

  • Kulkarni, S., Heath, C., Parker, S., Chase, A., Iqbal, S., Pocock, C.F., Kaeda, J., Cwynarski, K., Goldman, J.M., and Cross, N.C. (2000). Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21). Cancer Res 60, 3592–3598.

    PubMed  CAS  Google Scholar 

  • Kuo, Y.H., Landrette, S.F., Heilman, S.A., Perrat, P.N., Garrett, L., Liu, P.P., Le Beau, M.M., Kogan, S.C., and Castilla, L.H. (2006). Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia. Cancer Cell 9, 57–68.

    PubMed  CAS  Google Scholar 

  • La Starza, R., Sambani, C., Crescenzi, B., Matteucci, C., Martelli, M.F., and Mecucci, C. (2001). AML1/MTG16 fusion gene from a t(16;21)(q24;q22) translocation in treatment-induced leukemia after breast cancer. Haematologica 86, 212–213.

    PubMed  Google Scholar 

  • Lacronique, V., Boureux, A., Valle, V.D., Poirel, H., Quang, C.T., Mauchauffe, M., Berthou, C., Lessard, M., Berger, R., Ghysdael, J., et al. (1997). A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 278, 1309–1312.

    PubMed  CAS  Google Scholar 

  • Landis, S.H., Murray, T., Bolden, S., and Wingo, P.A. (1998). Cancer statistics, 1998. CA Cancer J Clin 48, 6–29.

    PubMed  CAS  Google Scholar 

  • Lee, S.Y., Reichlin, A., Santana, A., Sokol, K.A., Nussenzweig, M.C., and Choi, Y. (1997). TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival. Immunity 7, 703–713.

    PubMed  CAS  Google Scholar 

  • Leo, C., and Chen, J.D. (2000). The SRC family of nuclear receptor coactivators. Gene 245, 1–11.

    PubMed  CAS  Google Scholar 

  • Lessard, J., and Sauvageau, G. (2003). Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423, 255–260.

    PubMed  CAS  Google Scholar 

  • Levanon, D., Goldstein, R.E., Bernstein, Y., Tang, H., Goldenberg, D., Stifani, S., Paroush, Z., and Groner, Y. (1998). Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. Proc Natl Acad Sci USA 95, 11590–11595.

    PubMed  CAS  Google Scholar 

  • Li, D.M., and Sun, H. (1998). PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci USA 95, 15406–15411.

    PubMed  CAS  Google Scholar 

  • Li, S., Ilaria, R.L., Jr., Million, R.P., Daley, G.Q., and Van Etten, R.A. (1999). The P190, P210, and p230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med 189, 1399–1412.

    PubMed  CAS  Google Scholar 

  • Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S.I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997). PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943–1947.

    PubMed  CAS  Google Scholar 

  • Liang, J., Prouty, L., Williams, B.J., Dayton, M.A., and Blanchard, K.L. (1998). Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2. Blood 92, 2118–2122.

    PubMed  CAS  Google Scholar 

  • Lin, Y., Ryan, J., Lewis, J., Wani, M.A., Lingrel, J.B., and Liu, Z.G. (2003). TRAF2 exerts its antiapoptotic effect by regulating the expression of Kruppel-like factor LKLF. Mol Cell Biol 23, 5849–5856.

    PubMed  CAS  Google Scholar 

  • Liu, P., Tarle, S.A., Hajra, A., Claxton, D.F., Marlton, P., Freedman, M., Siciliano, M.J., and Collins, F.S. (1993). Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science 261, 1041–1044.

    PubMed  CAS  Google Scholar 

  • Liu, P.P., Wijmenga, C., Hajra, A., Blake, T.B., Kelley, C.A., Adelstein, R.S., Bagg, A., Rector, J., Cotelingam, J., Willman, C.L., et al. (1996). Identification of the chimeric protein product of the CBFβ-MYH11 fusion gene in inv(16) leukemia cells. Genes Chromosomes Cancer 16, 77–87.

    PubMed  Google Scholar 

  • Lou, J., Cao, W., Bernardin, F., Ayyanathan, K., Rauscher, I.F., and Friedman, A.D. (2000). Exogenous cdk4 overcomes reduced cdk4 RNA and inhibition of G1 progression in hematopoietic cells expressing a dominant-negative CBF – a model for overcoming inhibition of proliferation by CBF oncoproteins. Oncogene 19, 2695–2703.

    PubMed  CAS  Google Scholar 

  • Lutterbach, B., Westendorf, J.J., Linggi, B., Patten, A., Moniwa, M., Davie, J.R., Huynh, K.D., Bardwell, V.J., Lavinsky, R.M., Rosenfeld, M.G., et al. (1998). ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol Cell Biol 18, 7176–7184.

    PubMed  CAS  Google Scholar 

  • Ma, Z., Morris, S.W., Valentine, V., Li, M., Herbrick, J.A., Cui, X., Bouman, D., Li, Y., Mehta, P.K., Nizetic, D., et al. (2001). Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia. Nat Genet 28, 220–221.

    PubMed  CAS  Google Scholar 

  • Maki, K., Yamagata, T., Asai, T., Yamazaki, I., Oda, H., Hirai, H., and Mitani, K. (2005). Dysplastic definitive hematopoiesis in AML1/EVI1 knock-in embryos. Blood 106, 2147–2155.

    PubMed  CAS  Google Scholar 

  • Mercher, T., Coniat, M.B., Monni, R., Mauchauffe, M., Nguyen Khac, F., Gressin, L., Mugneret, F., Leblanc, T., Dastugue, N., Berger, R., et al. (2001). Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia. Proc Natl Acad Sci USA 98, 5776–5779.

    PubMed  CAS  Google Scholar 

  • Meyers, S., Downing, J.R., and Hiebert, S.W. (1993). Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the Runt homology domain is required for DNA binding and protein-protein interactions. Mol Cell Biol 13, 6336–6345.

    PubMed  CAS  Google Scholar 

  • Miething, C., Grundler, R., Fend, F., Hoepfl, J., Mugler, C., von Schilling, C., Morris, S.W., Peschel, C., and Duyster, J. (2003). The oncogenic fusion protein nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) induces two distinct malignant phenotypes in a murine retroviral transplantation model. Oncogene 22, 4642–4647.

    PubMed  CAS  Google Scholar 

  • Munzert, G., Kirchner, D., Stobbe, H., Bergmann, L., Schmid, R.M., Dohner, H., and Heimpel, H. (2002). Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B/Rel-regulated inhibitors of apoptosis. Blood 100, 3749–3756.

    PubMed  CAS  Google Scholar 

  • Murray, R.J., O’ReillyR.J., Cannell, P, French, M.A. (1999). B-cell acute lymphoblastic leukaemia in HIV infection. Annu Conf Australas Soc HIV Med, 11.

    Google Scholar 

  • Nakamura, T., Largaespada, D.A., Lee, M.P., Johnson, L.A., Ohyashiki, K., Toyama, K., Chen, S.J., Willman, C.L., Chen, I.M., Feinberg, A.P., et al. (1996). Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nat Genet 12, 154–158.

    PubMed  CAS  Google Scholar 

  • Nakazato, H., Shiozaki, H., Zhou, M., Nakatsu, M., Motoji, T., Mizoguchi, H., Miyawaki, S., and Sato, Y. (2001). TEL/MN1 fusion in a de novo acute myeloid leukaemia-M2 patient who showed strong resistance to treatment. Br J Haematol 113, 1079–1081.

    PubMed  CAS  Google Scholar 

  • Narducci, M.G., Pescarmona, E., Lazzeri, C., Signoretti, S., Lavinia, A.M., Remotti, D., Scala, E., Baroni, C.D., Stoppacciaro, A., Croce, C.M., et al. (2000). Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues. Cancer Res 60, 2095–2100.

    PubMed  CAS  Google Scholar 

  • Narducci, M.G., Stoppacciaro, A., Imada, K., Uchiyama, T., Virgilio, L., Lazzeri, C., Croce, C.M., and Russo, G. (1997). TCL1 is overexpressed in patients affected by adult T-cell leukemias. Cancer Res 57, 5452–5456.

    PubMed  CAS  Google Scholar 

  • Odero, M.D., Vizmanos, J.L., Roman, J.P., Lahortiga, I., Panizo, C., Calasanz, M.J., Zeleznik-Le, N.J., Rowley, J.D., and Novo, F.J. (2002). A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome. Genes Chromosomes Cancer 35, 11–19.

    PubMed  CAS  Google Scholar 

  • Okuda, T., Cai, Z., Yang, S., Lenny, N., Lyu, C.J., van Deursen, J.M., Harada, H., and Downing, J.R. (1998). Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors. Blood 91, 3134–3143.

    PubMed  CAS  Google Scholar 

  • Okuda, T., Takeda, K., Fujita, Y., Nishimura, M., Yagyu, S., Yoshida, M., Akira, S., Downing, J.R., and Abe, T. (2000). Biological characteristics of the leukemia-associated transcriptional factor AML1 disclosed by hematopoietic rescue of AML1-deficient embryonic stem cells by using a knock-in strateby. Mol Cell Biol 20, 319–328.

    PubMed  CAS  Google Scholar 

  • Onodera, M., Kunisada, T., Nishikawa, S., Sakiyama, Y., Matsumoto, S., and Nishikawa, S. (1995). Overexpression of retinoic acid receptor alpha suppresses myeloid cell differentiation at the promyelocyte stage. Oncogene 11, 1291–1298.

    PubMed  CAS  Google Scholar 

  • Pabst, T., Mueller, B.U., Harakawa, N., Schoch, C., Haferlach, T., Behre, G., Hiddemann, W., Zhang, D.E., and Tenen, D.G. (2001). AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia. Nat Med 7, 444–451.

    PubMed  CAS  Google Scholar 

  • Panagopoulos, I., Aman, P., Fioretos, T., Hoglund, M., Johansson, B., Mandahl, N., Heim, S., Behrendtz, M., and Mitelman, F. (1994). Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22). Genes Chromosomes Cancer 11, 256–262.

    PubMed  CAS  Google Scholar 

  • Panagopoulos, I., Fioretos, T., Isaksson, M., Samuelsson, U., Billstrom, R., Strombeck, B., Mitelman, F., and Johansson, B. (2001). Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13). Hum Mol Genet 10, 395–404.

    PubMed  CAS  Google Scholar 

  • Papadopoulos, P., Ridge, S.A., Boucher, C.A., Stocking, C., and Wiedemann, L.M. (1995). The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Res 55, 34–38.

    PubMed  CAS  Google Scholar 

  • Park, I.K., Qian, D., Kiel, M., Becker, M.W., Pihalja, M., Weissman, I.L., Morrison, S.J., and Clarke, M.F. (2003). Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423, 302–305.

    PubMed  CAS  Google Scholar 

  • Poiesz, B.J., Papsidero, L.D., Ehrlich, G., Sherman, M., Dube, S., Poiesz, M., Dillon, K., Ruscetti, F.W., Slamon, D., Fang, C., et al. (2001). Prevalence of HTLV-I-associated T-cell lymphoma. Am J Hematol 66, 32–38.

    PubMed  CAS  Google Scholar 

  • Poirel, H., Rack, K., Delabesse, E., Radford-Weiss, I., Troussard, X., Debert, C., Leboeuf, D., Bastard, C., Picard, F., Veil-Buzyn, A., et al. (1996). Incidence and characterization of MLL gene (11q23) rearrangements in acute myeloid leukemia M1 and M5. Blood 87, 2496–2505.

    PubMed  CAS  Google Scholar 

  • Raynaud, S.D., Baens, M., Grosgeorge, J., Rodgers, K., Reid, C.D., Dainton, M., Dyer, M., Fuzibet, J.G., Gratecos, N., Taillan, B., et al. (1996). Fluorescence in situ hybridization analysis of t(3; 12)(q26; p13): a recurring chromosomal abnormality involving the TEL gene (ETV6) in myelodysplastic syndromes. Blood 88, 682–689.

    PubMed  CAS  Google Scholar 

  • Rego, E.M., Ruggero, D., Tribioli, C., Cattoretti, G., Kogan, S., Redner, R.L., and Pandolfi, P.P. (2006). Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha. Oncogene 25, 1974–1979.

    PubMed  CAS  Google Scholar 

  • Rhoades, K.L., Hetherington, C.J., Harakawa, N., Yergeau, D.A., Zhou, L., Liu, L.Q., Little, M.T., Tenen, D.G., and Zhang, D.E. (2000). Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model. Blood 96, 2108–2115.

    PubMed  CAS  Google Scholar 

  • Ritchie, K.A., Aprikyan, A.A., Bowen-Pope, D.F., Norby-Slycord, C.J., Conyers, S., Bartelmez, S., Sitnicka, E.H., and Hickstein, D.D. (1999). The Tel-PDGFRbeta fusion gene produces a chronic myeloproliferative syndrome in transgenic mice. Leukemia 13, 1790–1803.

    PubMed  CAS  Google Scholar 

  • Rubnitz, J.E., Camitta, B.M., Mahmoud, H., Raimondi, S.C., Carroll, A.J., Borowitz, M.J., Shuster, J.J., Link, M.P., Pullen, D.J., Downing, J.R., et al. (1999). Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation. J Clin Oncol 17, 191–196.

    PubMed  CAS  Google Scholar 

  • Salomon-Nguyen, F., Busson-Le Coniat, M., Lafage Pochitaloff, M., Mozziconacci, J., Berger, R., and Bernard, O.A. (2000a). AML1-MTG16 fusion gene in therapy-related acute leukemia with t(16;21)(q24;q22): two new cases. Leukemia 14, 1704–1705.

    PubMed  CAS  Google Scholar 

  • Salomon-Nguyen, F., Della-Valle, V., Mauchauffe, M., Busson-Le Coniat, M., Ghysdael, J., Berger, R., and Bernard, O.A. (2000b). The t(1;12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion. Proc Natl Acad Sci USA 97, 6757–6762.

    CAS  Google Scholar 

  • Satake, N., Ishida, Y., Otoh, Y., Hinohara, S., Kobayashi, H., Sakashita, A., Maseki, N., and Kaneko, Y. (1997). Novel MLL-CBP fusion transcript in therapy-related chronic myelomonocytic leukemia with a t(11;16)(q23;p13) chromosome translocation. Genes Chromosomes Cancer 20, 60–63.

    PubMed  CAS  Google Scholar 

  • Sawyers, C.L., and Denny, C.T. (1994). Chronic myelomonocytic leukemia: Tel-a-kinase what Ets all about. Cell 77, 171–173.

    PubMed  CAS  Google Scholar 

  • Schwaller, J., Anastasiadou, E., Cain, D., Kutok, J., Wojiski, S., Williams, I.R., LaStarza, R., Crescenzi, B., Sternberg, D.W., Andreasson, P., et al. (2001). H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22). Blood 97, 3910–3918.

    PubMed  CAS  Google Scholar 

  • Schwaller, J., Frantsve, J., Aster, J., Williams, I.R., Tomasson, M.H., Ross, T.S., Peeters, P., Van Rompaey, L., Van Etten, R.A., Ilaria, R., Jr., et al. (1998). Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes. Embo J 17, 5321–5333.

    PubMed  CAS  Google Scholar 

  • Schwaller, J., Parganas, E., Wang, D., Cain, D., Aster, J.C., Williams, I.R., Lee, C.K., Gerthner, R., Kitamura, T., Frantsve, J., et al. (2000). Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. Mol Cell 6, 693–704.

    PubMed  CAS  Google Scholar 

  • Sherr, C.J. (2004). Principles of tumor suppression. Cell 116, 235–246.

    PubMed  CAS  Google Scholar 

  • Sobulo, O.M., Borrow, J., Tomek, R., Reshmi, S., Harden, A., Schlegelberger, B., Housman, D., Doggett, N.A., Rowley, J.D., and Zeleznik-Le, N.J. (1997). MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). Proc Natl Acad Sci USA 94, 8732–8737.

    PubMed  CAS  Google Scholar 

  • Soekarman, D., von Lindern, M., Daenen, S., de Jong, B., Fonatsch, C., Heinze, B., Bartram, C., Hagemeijer, A., and Grosveld, G. (1992). The translocation (6;9)(p23;q34) shows consistent rearrangement of two genes and defines a myeloproliferative disorder with specific clinical features. Blood 79, 2990–2997.

    PubMed  CAS  Google Scholar 

  • Stegmaier, K., Pendse, S., Barker, G.F., Bray-Ward, P., Ward, D.C., Montgomery, K.T., Krauter, K.S., Reynolds, C., Sklar, J., Donnelly, M., et al. (1995). Frequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood. Blood 86, 38–44.

    PubMed  CAS  Google Scholar 

  • Stirewalt, D.L., Kopecky, K.J., Meshinchi, S., Appelbaum, F.R., Slovak, M.L., Willman, C.L., and Radich, J.P. (2001). FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia. Blood 97, 3589–3595.

    PubMed  CAS  Google Scholar 

  • Strasser, A., Harris, A.W., and Cory, S. (1993). E mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells. Oncogene 8, 1–9.

    PubMed  CAS  Google Scholar 

  • Suzukawa, K., Shimizu, S., Nemoto, N., Takei, N., Taki, T., and Nagasawa, T. (2005). Identification of a chromosomal breakpoint and detection of a novel form of an MLL-AF17 fusion transcript in acute monocytic leukemia with t(11;17)(q23;q21). Int J Hematol 82, 38–41.

    PubMed  CAS  Google Scholar 

  • Taki, T., Sako, M., Tsuchida, M., and Hayashi, Y. (1997). The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. Blood 89, 3945–3950.

    PubMed  CAS  Google Scholar 

  • Takizawa, J., Suzuki, R., Kuroda, H., Utsunomiya, A., Kagami, Y., Joh, T., Aizawa, Y., Ueda, R., and Seto, M. (1998). Expression of the TCL1 gene at 14q32 in B-cell malignancies but not in adult T-cell leukemia. Jpn J Cancer Res 89, 712–718.

    PubMed  CAS  Google Scholar 

  • Tenen, D.G., Hromas, R., Licht, J.D., and Zhang, D.E. (1997). Transcription factors, normal myeloid development, and leukemia. Blood 90, 489–519.

    PubMed  CAS  Google Scholar 

  • Thick, J., Metcalfe, J.A., Mak, Y.F., Beatty, D., Minegishi, M., Dyer, M.J., Lucas, G., and Taylor, A.M. (1996). Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients. Oncogene 12, 379–386.

    PubMed  CAS  Google Scholar 

  • Tomasson, M.H., Sternberg, D.W., Williams, I.R., Carroll, M., Cain, D., Aster, J.C., Ilaria, R.L., Jr., Van Etten, R.A., and Gilliland, D.G. (2000). Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581. J Clin Invest 105, 423–432.

    PubMed  CAS  Google Scholar 

  • Torchia, J., Rose, D.W., Inostroza, J., Kamei, Y., Westin, S., Glass, C.K., and Rosenfeld, M.G. (1997). The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387, 677–684.

    PubMed  CAS  Google Scholar 

  • Tsai, S., and Collins, S.J. (1993). A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. Proc Natl Acad Sci USA 90, 7153–7157.

    PubMed  CAS  Google Scholar 

  • Tsuzuki, S., Seto, M., Greaves, M., and Enver, T. (2004). Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice. Proc Natl Acad Sci USA 101, 8443–8448.

    PubMed  CAS  Google Scholar 

  • Virgilio, L., Narducci, M.G., Isobe, M., Billips, L.G., Cooper, M.D., Croce, C.M., and Russo, G. (1994). Identification of the TCL1 gene involved in T-cell malignancies. Proc Natl Acad Sci USA 91, 12530–12534.

    PubMed  CAS  Google Scholar 

  • von Lindern, M., Fornerod, M., van Baal, S., Jaegle, M., de Wit, T., Buijs, A., and Grosveld, G. (1992). The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA. Mol Cell Biol 12, 1687–1697.

    Google Scholar 

  • Wang, C.Y., Mayo, M.W., Korneluk, R.G., Goeddel, D.V., and Baldwin, A.S., Jr. (1998). NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281, 1680–1683.

    PubMed  CAS  Google Scholar 

  • Westervelt, P., Lane, A.A., Pollock, J.L., Oldfather, K., Holt, M.S., Zimonjic, D.B., Popescu, N.C., DiPersio, J.F., and Ley, T.J. (2003). High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression. Blood 102, 1857–1865.

    PubMed  CAS  Google Scholar 

  • Wlodarska, I., Mecucci, C., Marynen, P., Guo, C., Franckx, D., La Starza, R., Aventin, A., Bosly, A., Martelli, M.F., Cassiman, J.J., et al. (1995). TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13). Blood 85, 2848–2852.

    PubMed  CAS  Google Scholar 

  • Yamamoto, Y., Kiyoi, H., Nakano, Y., Suzuki, R., Kodera, Y., Miyawaki, S., Asou, N., Kuriyama, K., Yagasaki, F., Shimazaki, C., et al. (2001). Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood 97, 2434–2439.

    PubMed  CAS  Google Scholar 

  • Yan, M., Burel, S.A., Peterson, L.F., Kanbe, E., Iwasaki, H., Boyapati, A., Hines, R., Akashi, K., and Zhang, D.E. (2004). Deletion of an AML1-ETO C-terminal NcoR/SMRT-interacting region strongly induces leukemia development. Proc Natl Acad Sci USA 101, 17186–17191.

    PubMed  CAS  Google Scholar 

  • Yokota, S., Kiyoi, H., Nakao, M., Iwai, T., Misawa, S., Okuda, T., Sonoda, Y., Abe, T., Kahsima, K., Matsuo, Y., et al. (1997). Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines. Leukemia 11, 1605–1609.

    PubMed  CAS  Google Scholar 

  • Yuan, Y., Zhou, L., Miyamoto, T., Iwasaki, H., Harakawa, N., Hetherington, C.J., Burel, S.A., Lagasse, E., Weissman, I.L., Akashi, K., et al. (2001). AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Proc Natl Acad Sci USA 98, 10398–10403.

    PubMed  CAS  Google Scholar 

  • Zapata, J.M., Krajewska, M., Krajewski, S., Kitada, S., Welsh, K., Monks, A., McCloskey, N., Gordon, J., Kipps, T.J., Gascoyne, R.D., et al. (2000). TNFR-associated factor family protein expression in normal tissues and lymphoid malignancies. J Immunol 165, 5084–5096.

    PubMed  CAS  Google Scholar 

  • Zhang, J., Grindley, J.C., Yin, T., Jayasinghe, S., He, X.C., Ross, J.T., Haug, J.S., Rupp, D., Porter-Westpfahl, K.S., Wiedemann, L.M., et al. (2006). PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 441, 518–522.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Jackson Laboratory, Bar Harbor, ME 04609, USA

    Shaoguang Li

Authors
  1. Yiguo Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shaoguang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

    Rights and permissions

    Reprints and permissions

    Copyright information

    © 2008 Springer Science+Business Media, LLC

    About this chapter

    Cite this chapter

    Hu, Y., Li, S. (2008). Genetic Modeling of Human Blood Cancers in Mice. In: Li, S. (eds) Mouse Models of Human Blood Cancers. Springer, New York, NY. https://doi.org/10.1007/978-0-387-69132-9_2

    Download citation

    Publish with us

    Policies and ethics

    Search

    Navigation